Noxopharm set for busy six months ahead with strong news flow expected from drug pipeline
Pharmaxis has multiple potential value inflection points with two drugs advancing in clinical trials
Anteris Technologies achieves “another standout year” as it progresses towards becoming market leader in combating aortic stenosis
Only registered members can use this feature.
Copyright © Proactive 2021.
All Rights Reserved - Proactive Australia PTY LTD ACN:132787654 ABN:19132787654.